507TiP PRESERVE 1: A phase III, randomized, double-blind trial of trilaciclib versus placebo in patients receiving FOLFOXIRI/bevacizumab for metastatic colorectal cancer
| Autor: | Hubbard, J.M., Aapro, M., Shah, S., Gabayan, A.E., Siegel, R., Pritchett, Y., Yi, J., Horton, J., Ciardiello, F. |
|---|---|
| Zdroj: | In Annals of Oncology September 2021 32 Supplement 5:S580-S580 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|